According to Myovant Sciences
's latest financial reports the company has a price-to-book ratio of -4.70.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | -4.68 | 38.61% |
2021-12-31 | -3.37 | -63.51% |
2020-12-31 | -9.24 | -67.57% |
2019-12-31 | -28.5 | -214.66% |
2018-12-31 | 24.9 | 165.08% |
2017-12-31 | 9.38 | 132.83% |
2016-12-31 | 4.03 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | -160.92% | ๐บ๐ธ USA |